nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol valerate/Dienogest—CYP3A4—Vandetanib—thyroid cancer	0.227	0.508	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Sorafenib—thyroid cancer	0.137	0.306	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Doxorubicin—thyroid cancer	0.0831	0.186	CbGbCtD
Estradiol valerate/Dienogest—Mood alteration NOS—Sorafenib—thyroid cancer	0.0435	0.0787	CcSEcCtD
Estradiol valerate/Dienogest—Acne—Vandetanib—thyroid cancer	0.0154	0.0278	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Vandetanib—thyroid cancer	0.0141	0.0256	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Sorafenib—thyroid cancer	0.00953	0.0172	CcSEcCtD
Estradiol valerate/Dienogest—Blood pressure increased—Sorafenib—thyroid cancer	0.00872	0.0158	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Vandetanib—thyroid cancer	0.00795	0.0144	CcSEcCtD
Estradiol valerate/Dienogest—Erythema nodosum—Epirubicin—thyroid cancer	0.00745	0.0135	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Vandetanib—thyroid cancer	0.00734	0.0133	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Vandetanib—thyroid cancer	0.00721	0.0131	CcSEcCtD
Estradiol valerate/Dienogest—Erythema nodosum—Doxorubicin—thyroid cancer	0.0069	0.0125	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal moniliasis—Epirubicin—thyroid cancer	0.00639	0.0116	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Vandetanib—thyroid cancer	0.00626	0.0113	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Vandetanib—thyroid cancer	0.00614	0.0111	CcSEcCtD
Estradiol valerate/Dienogest—Vulvovaginal candidiasis—Epirubicin—thyroid cancer	0.00613	0.0111	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Vandetanib—thyroid cancer	0.00607	0.011	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Vandetanib—thyroid cancer	0.00603	0.0109	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Sorafenib—thyroid cancer	0.006	0.0109	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal moniliasis—Doxorubicin—thyroid cancer	0.00591	0.0107	CcSEcCtD
Estradiol valerate/Dienogest—Vulvovaginal mycotic infection—Epirubicin—thyroid cancer	0.0059	0.0107	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Sorafenib—thyroid cancer	0.00572	0.0104	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Vandetanib—thyroid cancer	0.00569	0.0103	CcSEcCtD
Estradiol valerate/Dienogest—Vulvovaginal candidiasis—Doxorubicin—thyroid cancer	0.00567	0.0103	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Vandetanib—thyroid cancer	0.00565	0.0102	CcSEcCtD
Estradiol valerate/Dienogest—Vulvovaginal mycotic infection—Doxorubicin—thyroid cancer	0.00546	0.00988	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Vandetanib—thyroid cancer	0.00543	0.00984	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Sorafenib—thyroid cancer	0.00537	0.00971	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal discharge—Epirubicin—thyroid cancer	0.0053	0.00959	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Sorafenib—thyroid cancer	0.00495	0.00896	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal discharge—Doxorubicin—thyroid cancer	0.0049	0.00887	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00481	0.00871	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Vandetanib—thyroid cancer	0.0048	0.00868	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Sorafenib—thyroid cancer	0.00478	0.00866	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Vandetanib—thyroid cancer	0.00461	0.00835	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Vandetanib—thyroid cancer	0.00452	0.00819	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.00436	0.00788	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Sorafenib—thyroid cancer	0.0043	0.00779	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Sorafenib—thyroid cancer	0.00414	0.0075	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Sorafenib—thyroid cancer	0.00407	0.00736	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Vandetanib—thyroid cancer	0.00406	0.00735	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.00403	0.00729	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00398	0.00721	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Vandetanib—thyroid cancer	0.00398	0.0072	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Sorafenib—thyroid cancer	0.00396	0.00716	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Vandetanib—thyroid cancer	0.00395	0.00714	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Sorafenib—thyroid cancer	0.00384	0.00695	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Sorafenib—thyroid cancer	0.00381	0.0069	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00377	0.00683	CcSEcCtD
Estradiol valerate/Dienogest—Breast pain—Epirubicin—thyroid cancer	0.00369	0.00669	CcSEcCtD
Estradiol valerate/Dienogest—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00367	0.00664	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Sorafenib—thyroid cancer	0.00367	0.00664	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Vandetanib—thyroid cancer	0.00365	0.0066	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Epirubicin—thyroid cancer	0.00352	0.00637	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Sorafenib—thyroid cancer	0.00348	0.00631	CcSEcCtD
Estradiol valerate/Dienogest—Breast pain—Doxorubicin—thyroid cancer	0.00342	0.00619	CcSEcCtD
Estradiol valerate/Dienogest—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00339	0.00614	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Vandetanib—thyroid cancer	0.00331	0.00599	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Vandetanib—thyroid cancer	0.00326	0.00591	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00326	0.0059	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Epirubicin—thyroid cancer	0.00322	0.00584	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Epirubicin—thyroid cancer	0.00322	0.00584	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Sorafenib—thyroid cancer	0.00311	0.00563	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Sorafenib—thyroid cancer	0.00305	0.00552	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Vandetanib—thyroid cancer	0.00305	0.00552	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Epirubicin—thyroid cancer	0.00304	0.00551	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00298	0.0054	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00298	0.0054	CcSEcCtD
Estradiol valerate/Dienogest—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00296	0.00536	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Vandetanib—thyroid cancer	0.00293	0.00531	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Vandetanib—thyroid cancer	0.00291	0.00527	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Vandetanib—thyroid cancer	0.00291	0.00526	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Vandetanib—thyroid cancer	0.00289	0.00523	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Doxorubicin—thyroid cancer	0.00282	0.0051	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Vandetanib—thyroid cancer	0.00274	0.00496	CcSEcCtD
Estradiol valerate/Dienogest—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00274	0.00496	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Sorafenib—thyroid cancer	0.00274	0.00496	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Epirubicin—thyroid cancer	0.0027	0.00489	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00269	0.00486	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Sorafenib—thyroid cancer	0.00268	0.00486	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Sorafenib—thyroid cancer	0.00266	0.00482	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00254	0.00461	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Doxorubicin—thyroid cancer	0.0025	0.00453	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Sorafenib—thyroid cancer	0.00247	0.00447	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Sorafenib—thyroid cancer	0.00246	0.00445	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Epirubicin—thyroid cancer	0.00243	0.00439	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00239	0.00432	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Epirubicin—thyroid cancer	0.0023	0.00417	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Sorafenib—thyroid cancer	0.00229	0.00415	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Doxorubicin—thyroid cancer	0.00225	0.00407	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Sorafenib—thyroid cancer	0.00223	0.00404	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Epirubicin—thyroid cancer	0.00222	0.00401	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00221	0.004	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Sorafenib—thyroid cancer	0.0022	0.00399	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Doxorubicin—thyroid cancer	0.00213	0.00386	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Epirubicin—thyroid cancer	0.00211	0.00383	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Sorafenib—thyroid cancer	0.00206	0.00372	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Doxorubicin—thyroid cancer	0.00205	0.00371	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Epirubicin—thyroid cancer	0.00204	0.00369	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Epirubicin—thyroid cancer	0.00202	0.00366	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Epirubicin—thyroid cancer	0.00198	0.00359	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Sorafenib—thyroid cancer	0.00198	0.00358	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Sorafenib—thyroid cancer	0.00196	0.00355	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Sorafenib—thyroid cancer	0.00196	0.00355	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Doxorubicin—thyroid cancer	0.00196	0.00354	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Sorafenib—thyroid cancer	0.00195	0.00353	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Doxorubicin—thyroid cancer	0.00188	0.00341	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Doxorubicin—thyroid cancer	0.00187	0.00339	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Sorafenib—thyroid cancer	0.00185	0.00335	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Epirubicin—thyroid cancer	0.00184	0.00333	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Doxorubicin—thyroid cancer	0.00183	0.00332	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Epirubicin—thyroid cancer	0.00183	0.00331	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Doxorubicin—thyroid cancer	0.0017	0.00308	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Doxorubicin—thyroid cancer	0.00169	0.00306	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Epirubicin—thyroid cancer	0.00159	0.00288	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Epirubicin—thyroid cancer	0.00156	0.00282	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Epirubicin—thyroid cancer	0.00153	0.00277	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Epirubicin—thyroid cancer	0.00151	0.00274	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Epirubicin—thyroid cancer	0.0015	0.00272	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00147	0.00266	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Epirubicin—thyroid cancer	0.00146	0.00265	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Doxorubicin—thyroid cancer	0.00144	0.00261	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Epirubicin—thyroid cancer	0.00142	0.00257	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Doxorubicin—thyroid cancer	0.00142	0.00256	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Epirubicin—thyroid cancer	0.00141	0.00255	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Doxorubicin—thyroid cancer	0.0014	0.00253	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Doxorubicin—thyroid cancer	0.00139	0.00252	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Epirubicin—thyroid cancer	0.00139	0.00251	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Epirubicin—thyroid cancer	0.00138	0.0025	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Epirubicin—thyroid cancer	0.00137	0.00248	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Epirubicin—thyroid cancer	0.00135	0.00245	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Doxorubicin—thyroid cancer	0.00135	0.00245	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Doxorubicin—thyroid cancer	0.00131	0.00238	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Doxorubicin—thyroid cancer	0.0013	0.00236	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Doxorubicin—thyroid cancer	0.00128	0.00233	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Doxorubicin—thyroid cancer	0.00128	0.00232	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Doxorubicin—thyroid cancer	0.00127	0.00229	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Doxorubicin—thyroid cancer	0.00125	0.00227	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Epirubicin—thyroid cancer	0.00125	0.00225	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Epirubicin—thyroid cancer	0.0012	0.00216	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Doxorubicin—thyroid cancer	0.00115	0.00209	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Epirubicin—thyroid cancer	0.00115	0.00208	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Epirubicin—thyroid cancer	0.00115	0.00208	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Epirubicin—thyroid cancer	0.00113	0.00204	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Doxorubicin—thyroid cancer	0.00111	0.002	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00106	0.00193	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Doxorubicin—thyroid cancer	0.00106	0.00193	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Doxorubicin—thyroid cancer	0.00104	0.00189	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Epirubicin—thyroid cancer	0.00101	0.00183	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000993	0.0018	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Epirubicin—thyroid cancer	0.000992	0.00179	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Epirubicin—thyroid cancer	0.000984	0.00178	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000941	0.0017	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Doxorubicin—thyroid cancer	0.000937	0.0017	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000919	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Doxorubicin—thyroid cancer	0.000918	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Epirubicin—thyroid cancer	0.000914	0.00165	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Doxorubicin—thyroid cancer	0.00091	0.00165	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Epirubicin—thyroid cancer	0.000909	0.00165	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00087	0.00158	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Epirubicin—thyroid cancer	0.000847	0.00153	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Doxorubicin—thyroid cancer	0.000845	0.00153	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Doxorubicin—thyroid cancer	0.000841	0.00152	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Epirubicin—thyroid cancer	0.000825	0.00149	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Epirubicin—thyroid cancer	0.000814	0.00147	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Doxorubicin—thyroid cancer	0.000784	0.00142	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Doxorubicin—thyroid cancer	0.000764	0.00138	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Epirubicin—thyroid cancer	0.000761	0.00138	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Doxorubicin—thyroid cancer	0.000753	0.00136	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Epirubicin—thyroid cancer	0.000731	0.00132	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Epirubicin—thyroid cancer	0.000725	0.00131	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Epirubicin—thyroid cancer	0.000725	0.00131	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Epirubicin—thyroid cancer	0.000721	0.0013	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Doxorubicin—thyroid cancer	0.000704	0.00127	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Epirubicin—thyroid cancer	0.000683	0.00124	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Doxorubicin—thyroid cancer	0.000677	0.00122	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Doxorubicin—thyroid cancer	0.000671	0.00121	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Doxorubicin—thyroid cancer	0.00067	0.00121	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Doxorubicin—thyroid cancer	0.000667	0.00121	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Doxorubicin—thyroid cancer	0.000632	0.00114	CcSEcCtD
